Risk-based quality management (RBQM) is becoming central to clinical trial oversight, with ICH E6(R3) emphasising proportional, patient-focused approaches. Sponsors and CROs are moving away from rigid monitoring plans toward strategies that embed quality throughout trial design and execution.
